News

A genetically modified herpes virus, also known as RP1, could soon be getting the green light to be approved by US and ...
Approval was based on results from the DOORwaY90 trial, which demonstrated a 98.5% overall response rate and 100% local tumor control in patients treated with the SIR-Spheres Y-90 resin microspheres ...
NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the ...
Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...
Colon cancer rates are rising sharply in Americans under 50, with 53,000 deaths expected in 2025. Experts link the surge to obesity, poor diet, and delayed diagnoses in younger patients.
Immune checkpoint inhibitors (ICIs) are revolutionizing cancer treatment by helping the immune system better find and attack ...
Genetic testing revealed that she was positive for BRCA1, a genetic mutation that increases one’s risk of breast and ovarian ...
A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...
As early-onset cancers rise, more people are faced with the question of how their treatment might affect their ability to ...
Emily Haley had a small, red bump on her forehead that she first thought was a stubborn pimple. It was actually basal cell ...
Home-based cancer care is safe, feasible, and preferred by most patients, according to early findings from a Mayo Clinic ...